PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 28, 2005The Journal of Experimental Medicine1,100 citationsOpen Access

The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion

ATAllan TsungRSRohit SahaiHTHiroyuki Tanaka

Key Points

Key points are not available for this paper at this time.

Abstract

High-mobility group box 1 (HMGB1) is a nuclear factor that is released extracellularly as a late mediator of lethality in sepsis as well as after necrotic, but not apoptotic, death. Here we demonstrate that in contrast to the delayed role of HMGB1 in the systemic inflammation of sepsis, HMGB1 acts as an early mediator of inflammation and organ damage in hepatic ischemia reperfusion (I/R) injury. HMGB1 levels were increased during liver I/R as early as 1 h after reperfusion and then increased in a time-dependent manner up to 24 h. Inhibition of HMGB1 activity with neutralizing antibody significantly decreased liver damage after I/R, whereas administration of recombinant HMGB1 worsened I/R injury. Treatment with neutralizing antibody was associated with less phosphorylation of c-Jun NH(2)-terminal kinase and higher nuclear factor-kappaB DNA binding in the liver after I/R. Toll-like receptor 4 (TLR4)-defective (C3H/Hej) mice exhibited less damage in the hepatic I/R model than did wild-type (C3H/HeOuj) mice. Anti-HMGB1 antibody failed to provide protection in C3H/Hej mice, but successfully reduced damage in C3H/Ouj mice. Together, these results demonstrate that HMGB1 is an early mediator of injury and inflammation in liver I/R and implicates TLR4 as one of the receptors that is involved in the process.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Tsung et al. (2005) studied this question.

synapsesocial.com/papers/6a24b1e3a0f042481427901fhttps://doi.org/10.1084/jem.20042614
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Oligosaccharides of Hyaluronan Activate Dendritic Cells via Toll-like Receptor 42002 · 1,373 citations
  2. 2QUANTIFICATION OF MURINE CYTOKINE mRNAs USING REAL TIME QUANTITATIVE REVERSE TRANSCRIPTASE PCR1999 · 561 citations
  3. 3Hepatic ischemia/reperfusion injury—a fresh look2003 · 409 citations
  4. 4Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways1996 · 1,554 citations
  5. 5Fibrinogen Stimulates Macrophage Chemokine Secretion Through Toll-Like Receptor 42001 · 955 citations